Gates Foundation invests €5 million in Basel-based Axmed to expand affordable medicines distribution in low- and middle-income countries.
Author: Aron Bowers
A key MSCI index approval is set to make Bitcoin treasury allocations viable for major public companies and institutions from 2026, reshaping corporate reserve strategy.
At Davos 2026, investors weigh Trump-era US deregulation against Europe’s fragmented ‘EU Inc’ model and ask whether capital-light founders can still win in Europe.
SpaceX has reportedly chosen major Wall Street banks, including BofA, Goldman Sachs, JPMorgan and Morgan Stanley, to lead a potential IPO that could value the company above $350 billion.
Ukrainian President Volodymyr Zelensky expresses cautious optimism ahead of historic trilateral talks with US and Russian officials in the UAE, stating that peace documents are “nearly ready” despite unresolved territorial disputes. DAVOS / ABU DHABI — In a pivotal moment for the nearly four-year-long conflict, Ukrainian President Volodymyr Zelensky announced on Friday that the first-ever trilateral peace talks involving Ukraine, Russia, and the United States have commenced in the United Arab Emirates. Speaking from the World Economic Forum in Davos, Zelensky framed the high-stakes meeting as a potential turning point, expressing hope that it would serve as a definitive “step…
Croatia is quietly emerging as a Balkan tech hotspot. Here are 10 homegrown startups poised to shape its innovation story in 2026 and beyond.
Bitcoin volatility hits historic lows in early 2026 as Wall Street cements control, shifting the speculative frenzy toward the booming Real World Assets sector. NEW YORK — As the first trading week of 2026 concludes, the cryptocurrency market presents a picture drastically different from the chaotic cycles of the past decade. On January 8, data from major exchanges reveals a market that has matured—perhaps too much for the adrenaline-seeking retail trader—but exactly enough for the global financial elite. The “Wild West” era appears to be officially over, replaced by a landscape defined by regulatory compliance, institutional accumulation, and the rapid…
Icelandic biotech Alvotech secures a €100 million term loan to strengthen liquidity, accelerate biosimilar R&D and support its path to global market expansion.
US pharma giant Amgen is acquiring Oxford-based Dark Blue for up to €718M, strengthening its leukemia drug pipeline and deepening its UK R&D footprint.
EU policymakers in Brussels are advancing reforms to reduce Europe’s internal fragmentation, aiming to unlock growth, scale startups, and strengthen competitiveness.